“Bimekizumab-induced eczematous eruption treated successfully with sequential upadacitinib and dupilumab therapy” (2025) SKIN The Journal of Cutaneous Medicine, 9(3), pp. 2330–2333. doi:10.25251/skin.9.3.8.